Catalog No.
YVV19904
Expression system
E. coli
Species
Dengue virus type 4 (strain Thailand/0348/1991) (DENV-4)
Protein length
Met576-Lys679
Predicted molecular weight
13.46 kDa
Nature
Recombinant
Endotoxin level
Please contact with the lab for this information.
Purity
>90% as determined by SDS-PAGE.
Accession
Q2YHF0
Applications
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Reconstitution
Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.
Shipping
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative Names
Genome polyprotein, Capsid protein C, Core protein, Protein prM, Peptide pr, Small envelope protein M, Matrix protein, Envelope protein E, Non-structural protein 1, NS1, Non-structural protein 2A, NS2A, Serine protease subunit NS2B, Flavivirin protease NS2B regulatory subunit, Non-structural protein 2B, Serine protease NS3, 3.4.21.91, 3.6.1.15, 3.6.4.13, Flavivirin protease NS3 catalytic subunit, Non-structural protein 3, Non-structural protein 4A, NS4A, Peptide 2k, Non-structural protein 4B, NS4B, RNA-directed RNA polymerase NS5, 2.1.1.56, 2.1.1.57, 2.7.7.48, Non-structural protein 5
Antiviral in vitro activity of a novel dichlorinated tyrosine methyl ester derivative against the infection of two flaviviruses of public health concern, dengue and zika virus., PMID:40450991
Development of New Live-Attenuated Vaccine Candidates Lacking Antibody-Dependent Enhancement (ADE) Against Dengue., PMID:40432141
miRNome analysis reveals mir-155-5p as a protective factor to dengue infection in a resistant Thai cohort., PMID:39976655
RT-RPA Assisted CRISPR/Cas12a Based One-Pot Rapid and Visual Detection of the Pan-Dengue Virus., PMID:39949262
Genetic diversity of dengue virus circulating in the Philippines (2014-2019) and comparison with dengue vaccine strains., PMID:39700304
Efficacy and safety of Butantan-DV in participants aged 2-59 years through an extended follow-up: results from a double-blind, randomised, placebo-controlled, phase 3, multicentre trial in Brazil., PMID:39116904
A 2D-proteomic analysis identifies proteins differentially regulated by two different dengue virus serotypes., PMID:38594317
E-Protein Protonation Titration-Induced Single-Particle Chemical Force Spectroscopy for Microscopic Understanding and pI Estimation of Infectious DENV., PMID:38512319
Characterization of Dengue Virus 4 Cases in Paraguay, 2019-2020., PMID:38399957
Live, Attenuated, Tetravalent Butantan-Dengue Vaccine in Children and Adults., PMID:38294972
Serotype-associated immune response and network immunoclusters in children and adults during acute Dengue virus infection., PMID:37542834
Epitope prediction and designing of receptor inhibitor of Dengue Envelope Protein: An in silico approach., PMID:37417165
Experimental Dengue Virus Type 4 Infection Increases the Expression of MicroRNAs-15/16, Triggering a Caspase-Induced Apoptosis Pathway., PMID:37367040
Isolation and Genetic Evolution of Dengue Virus from the 2019 Outbreak in Xishuangbanna, Yunnan Province, China., PMID:37184906
Primary infection of BALB/c mice with a dengue virus type 4 strain leads to kidney injury., PMID:37162062
Evolutionary dynamics of dengue virus in India., PMID:37011104
Development of novel antiviral peptides against dengue serotypes 1-4., PMID:36739680
The dengue virus 4 component of NIAID's tetravalent TV003 vaccine drives its innate immune signature., PMID:36734144
Genetic diversity and spatiotemporal dynamics of DENV-1 and DENV-2 infections during the 2012-2013 outbreak in Mexico., PMID:35779336
Molecular Characterization and Identification of Potential Inhibitors for 'E' Protein of Dengue Virus., PMID:35632682
Mathematical models for dengue fever epidemiology: A 10-year systematic review., PMID:35219611
Virus-like particles with FLAG-tagged envelope protein as a tetravalent dengue vaccine candidate., PMID:34475493
Co-Circulation of All Four Dengue Viruses and Zika Virus in Guerrero, Mexico, 2019., PMID:33944623
Renal Injury in DENV-4 Fatal Cases: Viremia, Immune Response and Cytokine Profile., PMID:31703246
Spatio-temporal distribution analysis of circulating genotypes of dengue virus type 1 in western and southern states of India by a one-step real-time RT-PCR assay., PMID:31376506
Phylogenetic analysis of partial pre-membrane and envelope sequences of dengue viruses circulating in India., PMID:31002930
A Stillborn Multiple Organs' Investigation from a Maternal DENV-4 Infection: Histopathological and Inflammatory Mediators Characterization., PMID:30986974
Electroporation-Mediated Immunization of a Candidate DNA Vaccine Expressing Dengue Virus Serotype 4 prM-E Antigen Confers Long-Term Protection in Mice., PMID:30790202
Development of a Standardized Sanger-Based Method for Partial Sequencing and Genotyping of Dengue Viruses., PMID:30760533
In vitro analysis of synthetic peptides in blocking the entry of dengue virus., PMID:30508603
Emergence of dengue virus type 1 and type 3 as dominant serotypes during 2017 in Pune and Nashik regions of Maharashtra, Western India., PMID:30366083
Improvement of the Dengue Virus (DENV) Nonhuman Primate Model via a Reverse Translational Approach Based on Dengue Vaccine Clinical Efficacy Data against DENV-2 and -4., PMID:29593041
Pichia pastoris-Expressed Bivalent Virus-Like Particulate Vaccine Induces Domain III-Focused Bivalent Neutralizing Antibodies without Antibody-Dependent Enhancement in Vivo., PMID:29367852
Genetic epidemiology of dengue viruses in phase III trials of the CYD tetravalent dengue vaccine and implications for efficacy., PMID:28871961
Epidemiological and molecular characteristics of emergent dengue virus in Yunnan Province near the China-Myanmar-Laos border, 2013-2015., PMID:28482813
Increased sensitivity of NS1 ELISA by heat dissociation in acute dengue 4 cases., PMID:28284209
Recombinant Dengue Virus 4 Envelope Glycoprotein Virus-Like Particles Derived from Pichia pastoris are Capable of Eliciting Homotypic Domain III-Directed Neutralizing Antibodies., PMID:27821688
Virus-like particles derived from Pichia pastoris-expressed dengue virus type 1 glycoprotein elicit homotypic virus-neutralizing envelope domain III-directed antibodies., PMID:27301568
Population genomics of dengue virus serotype 4: insights into genetic structure and evolution., PMID:27169727
Characterization of the 2013 dengue epidemic in Myanmar with dengue virus 1 as the dominant serotype., PMID:27154331
Development of a recombinant, chimeric tetravalent dengue vaccine candidate., PMID:26585500
Comprehensive mapping of functional epitopes on dengue virus glycoprotein E DIII for binding to broadly neutralizing antibodies 4E11 and 4E5A by phage display., PMID:26339794
Comparison of E and NS1 antigens capture ELISA to detect dengue viral antigens from mosquitoes., PMID:26119545
Vector competence of the Aedes aegypti population from Santiago Island, Cape Verde, to different serotypes of dengue virus., PMID:25888847
Computational prediction and analysis of envelop glycoprotein epitopes of DENV-2 and DENV-3 Pakistani isolates: a first step towards Dengue vaccine development., PMID:25775090
Nonstructural protein 1-specific immunoglobulin M and G antibody capture enzyme-linked immunosorbent assays in diagnosis of flaviviral infections in humans., PMID:25502522
False-negative dengue cases in Roraima, Brazil: an approach regarding the high number of negative results by NS1 ag kits., PMID:25229228
Continuous dengue type 1 virus genotype shifts followed by co-circulation, clade shifts and subsequent disappearance in Surabaya, Indonesia, 2008-2013., PMID:25219342
Dengue virus 2 American-Asian genotype identified during the 2006/2007 outbreak in Piauí, Brazil reveals a Caribbean route of introduction and dissemination of dengue virus in Brazil., PMID:25127366
[Selection of heparin-sensitive dengue virus variants in BHK-21 cells]., PMID:24974631
For research use only. Not for human or drug use.
